Target intelligence / Profile preview

Vibrio cholerae O1 lipopolysaccharide O-specific polysaccharide (OSP)

Target
OSP
Molecular classification
Polysaccharide, Bacterial surface antigen, Lipopolysaccharide component
01

Overview

The Vibrio cholerae O1 lipopolysaccharide O-specific polysaccharide (OSP) is the primary immunodominant surface antigen of the Gram-negative bacterium responsible for epidemic cholera (Xu et al., 2011, PubMed). It consists of a homopolymer of α(1→2)-linked 4-amino-4,6-dideoxy-D-mannose (D-perosamine) residues, which are acylated with 3-deoxy-L-glycero-tetronic acid (Meeks et al., 2020, NIH). This molecule is a critical component of the bacterial outer membrane, providing structural integrity and acting as a shield against host complement-mediated killing and environmental stressors. In the context of therapeutics, OSP is the central target for all WHO-prequalified oral cholera vaccines (OCVs), which aim to elicit high titers of vibriocidal antibodies and mucosal IgA to prevent intestinal colonization (Wierzba et al., 2015, PubMed). The chemical structure of the OSP determines the serotype of the V. cholerae O1 strain, specifically the Ogawa and Inaba serotypes, which differ by the presence or absence of a single methyl group on the terminal sugar residue (Villeneuve et al., 1999, PubMed). Because immunity to cholera is largely serogroup-specific, the OSP is also the primary focus for rapid diagnostic tests and epidemiological surveillance during outbreaks.

Other names
O-antigenO-specific polysaccharideV. cholerae O1 OSPO-side chainVibrio cholerae O1 LPS
02

Mechanism of action

Induction of protective mucosal IgA and serum vibriocidal antibodies that inhibit bacterial motility and attachment to the intestinal epithelium.

03

Biological functions

Bacterial cell wall integrityImmune evasionSerotype specificityProtection against environmental stressBacterial colonization
04

Disease associations

InfectionCholera
05

Safety considerations

ReactogenicitySerotype switching (e.g., O1 to O139)Short-lived immunity in young childrenRisk of environmental degradation of oral vaccines
06

Interacting drugs

Dukoral

4 more in the full profile.

07

Biomarkers

Vibriocidal antibody titerAnti-OSP IgA levelsAnti-OSP IgG levels

Beyond the preview

Go deeper on Vibrio cholerae O1 lipopolysaccharide O-specific polysaccharide (OSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vibrio cholerae O1 lipopolysaccharide O-specific polysaccharide (OSP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call